The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The prospectus hasn't landed on the website. Maybe later today?
So the director sold two months ago? That's old news, I thought it was something new. Moneybox sells two months after the fact.
Where does it show that the CEO sold 4 million shares? I can't find any proof of it.
I'm certain there will be a vaccine. There are many trials going on, and with so many of our top scientists involved, someone will get it right, plus all the drug trials out there too!
The market will wake up once Dev start showing the revenue figures, which I'm betting on being positive. At the moment it's too soon for Dev to go beyond 10p.
Barnard, if they are trading ahead of their own expectations, then it would be useful to post a RNS telling us that. I watched Richard's interview, a lot to be excited about. It all looks positive.